Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Intravitreal Bevacizumab in Recalcitrant Inflammatory Ocular Neovascularization (AVA-ION)

This study has been completed.
Sponsor:
Collaborators:
Heidelberg University
University Hospital Tuebingen
University Hospital Freiburg
Information provided by:
Rafic Hariri University Hospital
ClinicalTrials.gov Identifier:
NCT00645697
First received: March 25, 2008
Last updated: NA
Last verified: March 2008
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2008
  Primary Completion Date: March 2008 (Final data collection date for primary outcome measure)
No publications provided by Rafic Hariri University Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):